| 1 |
Fishman JA. Infection in organ transplantation[J]. Am J Transplant, 2017，17(4)：856-879.
|
| 2 |
Fehr T, Bossart W, Wahl C, et al. Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature[J]. Transplantation, 2002, 73(4)：608-611.
|
| 3 |
driguez-Moreno A, Sanchez-Fructuoso AI, Calvo N, et al. Varicella infection in adult renal allograft recipients: experience at one center[J]. Transplant Proc, 2006, 38(8)：2416-2418.
|
| 4 |
Mustapic Z, Basic-Jukic N, Kes P, et al. Varicella zoster infection in renal transplant recipients: prevalence, complications and outcome[J]. Kidney Blood Press Res, 2011, 34 (6)：382-386.
|
| 5 |
Kwon DE, Lee HS, Lee KH, et al. Incidence of herpes zoster in adult solid organ transplant recipients: a meta-analysis and comprehensive review[J]. Transpl Infect Dis, 2021, 23(4)：e13674.
|
| 6 |
Kho MML, Roest S, Bovée DM, et al. Herpes zoster in solid organ transplantation: incidence and risk factors[J]. Front Immunol, 2021, 12: 645718.
|
| 7 |
Stratman E． Visceral zoster as the presenting feature of disseminated herpes zoster[J]. J Am Acad Dermatol, 2002, 46(5)：771-774.
|
| 8 |
Miller GG, Dummer JS. Herpes simplex and varicella zoster viruses: forgotten but not gone[J]. Am J Transplant, 2007, 7(4)：741-747.
|
| 9 |
Rommelaere MR, Maréchal CM, Yombi JY. Disseminated varicella zoster virus infection in adult renal transplant recipients: outcome and risk factors[J]. Transplant Proc, 2012, 44(9)：2814-2817.
|
| 10 |
Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster[J]. N Engl J Med, 2007, 356(13)：1338-1343.
|
| 11 |
索罗丹，赵丹，陈萌，等. 北京市健康人群水痘-带状疱疹病毒血清抗体水平调查分析[J]. 中华预防医学杂志，2022, 56(2)：108-113.
|
| 12 |
Schub D, Janssen E, Leyking S, et al. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection[J]. J Infect Dis, 2015, 211(4)：600-612.
|
| 13 |
Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection[J]. Annu Rev Pathol, 2019, 14：319-338.
|
| 14 |
Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults[J]. N Engl J Med, 2015, 372(22)：2087-2096.
|
| 15 |
Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older[J]. N Engl J Med, 2016, 375(11)：1019-1032.
|
| 16 |
Marra F, Yip M, Cragg JJ, et al. Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations[J]. PLoS One, 2024, 19(11): e0313889.
|
| 17 |
Vink P, Ramon TJ, Sanchez FA, et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial[J]. Clin Infect Dis, 2020, 70(2)：181-190.
|